Effects of preanalytical variables on peptide and protein measurements in human serum and plasma: implications for clinical proteomics

References

• Bonini P, Plebani M, Ceriotti F, Rubboli F. Errors in laboratory medicine. Clin. Chem.48(5), 691–698 (2002).
   PubMed Web of Science ®Google Scholar
• Boone DJ, Steindel SD, Herron R et al. Transfusion medicine monitoring practices. A study of the College of American Pathologists/Centers for Disease Control and Prevention Outcomes Working Group. Arch. Pathol. Lab. Med.119(11), 999–1006 (1995).
   PubMedGoogle Scholar
• Plebani M, Carraro P. Mistakes in a stat laboratory: types and frequency. Clin. Chem.43(8 Pt 1), 1348–1351 (1997).
   PubMed Web of Science ®Google Scholar
• Schleicher E. The clinical chemistry laboratory: current status, problems and diagnostic prospects. Anal. Bioanal. Chem.384(1), 124–131 (2006).
   PubMedGoogle Scholar
• Bons JA, de Boer D, van Dieijen-Visser MP, Wodzig WK. Standardization of calibration and quality control using surface enhanced laser desorption ionization-time of flight-mass spectrometry. Clin. Chim. Acta.366(1–2), 249–256 (2006).
   PubMed Web of Science ®Google Scholar
• Colantonio DA, Chan DW. The clinical application of proteomics. Clin. Chim. Acta.357(2), 151–158 (2005).
   PubMed Web of Science ®Google Scholar
• Karsan A, Eigl BJ, Flibotte S et al. Analytical and preanalytical biases in serum proteomic pattern analysis for breast cancer diagnosis. Clin. Chem.51(8), 1525–1528 (2005).
   PubMed Web of Science ®Google Scholar
• Marshall J, Kupchak P, Zhu W et al. Processing of serum proteins underlies the mass spectral fingerprinting of myocardial infarction. J. Proteome Res.2(4), 361–372 (2003).
   PubMed Web of Science ®Google Scholar
• Anderson NL, Anderson NG. The human plasma proteome: history, character, and diagnostic prospects. Mol. Cell. Proteomics1(11), 845–867 (2002).
   PubMed Web of Science ®Google Scholar
• Glover Leonard & Redshaw Management Consultancy. Laboratory Workload Segmentation Audit of Medium to High Specimen Throughput Laboratory Locations in Europe. Glover Leonard & Redshaw: Brussels, Bronxville, USA, 71 (1997).
   Google Scholar
• Clinical and Laboratory Standards Institute. Protocols for determination of limits of detection and limits of quantitation; approved guideline EP-17A. (2004).
   Google Scholar
• Clinical and Laboratory Standards Institute. Evaluation of the linearity of quantitative measurement procedures, a statistical approach; approved guideline, EP6-A. (2003).
   Google Scholar
• Clinical and Laboratory Standards Institute. Evaluation of precision performance of quantitative measurement methods; approved guideline EP5-A2. 2nd Edition (2004).
   Google Scholar
• Vitzthum F, Behrens F, Anderson NL, Shaw JH. Proteomics: from basic research to diagnostic application. A review of requirements & needs. J. Proteome Res.4(4), 1086–1097 (2005).
   PubMed Web of Science ®Google Scholar
• National Committe for Clinical and Laboratory Standards. Procedures For Collection of Diagnostic Blood Specimens by Veninpuncture: Approved Standard H3-A4, 4th Edition (1991).
   Google Scholar
• National Committe for Clinical and Laboratory Standards. Procedures for the Handling and Transport of Domestic Diagnostic Specimens and Etiologic Agents: Approved Standard H5-A3, 3rd Edition (1994).
   Google Scholar
• National Committe for Clinical and Laboratory Standards. Evacuated Tubes and Additives for Blood Specimen Collection: Approved Standard H1-A4, 4th Edition (1996).
   Google Scholar
• National Committe for Clinical and Laboratory Standards. Blood Collection on Filter Paper for Neonatal Screening Programs: approved standard LA4-A3, 3rd Edition (1997).
   Google Scholar
• National Committe for Clinical and Laboratory Standards. Procedures for Collection of Skin Puncture Blood Specimens: Approved Standard, H4-A4, 4th Edition (2000).
   Google Scholar
• Empfehlung der Arbeitsgruppe Präanalytik der Deutschen Gesellschaft für Klinsiche Chemie und der Detuschen Gesellschaft für Laboratoriumsmedizin. Die Qualität Diagnostischer Proben Edition 4 (2003).
   Google Scholar
• Hortin GL. Can mass spectrometric protein profiling meet desired standards of clinical laboratory practice? Clin. Chem.51(1), 3–5 (2005).
   PubMed Web of Science ®Google Scholar
• Lathia CD. Biomarkers and surrogate endpoints: how and when might they impact drug development? Dis. Markers18(2), 83–90 (2002).
   PubMedGoogle Scholar
• Temple R. Are surrogate markers adequate to assess cardiovascular disease drugs? JAMA282(8), 790–795 (1999).
   PubMed Web of Science ®Google Scholar
• Morimoto T, Hayashino Y, Shimbo T, Izumi T, Fukui T. Is B-type natriuretic peptide-guided heart failure management cost-effective? Int. J. Cardiol.96(2), 177–181 (2004).
   PubMed Web of Science ®Google Scholar
• Michelson AD, Cattaneo M, Eikelboom JW et al. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J. Thromb. Haemost.3(6), 1309–1311 (2005).
   PubMed Web of Science ®Google Scholar
• Voorbiy HAM, Meijre-Huissen CH, Kuijpers EW. Pouten en risiko’s in een klinisch-chemisch laboratrium.19, 36–41 (1994).
   Google Scholar
• Winsten S, Gordesky SE. Transportation of Specimens. In: Selected Methods of Clinical Chemistry. Faulkner WR (Ed.). American Association for Clinical Chemistry, 9, 11–15 (1982).
   Google Scholar
• Rai AJ, Gelfand CA, Haywood BC et al. HUPO Plasma Proteome Project specimen collection and handling: towards the standardization of parameters for plasma proteome samples. Proteomics5(13), 3262–3277 (2005).
   PubMed Web of Science ®Google Scholar
• Livesey JH, Hodgkinson SC, Roud HR, Donald RA. Effect of time, temperature and freezing on the stability of immunoreactive LH, FSH, TSH, growth hormone, prolactin and insulin in plasma. Clin. Biochem.13(4), 151–155 (1980).
   PubMed Web of Science ®Google Scholar
• Schram JL, Pearson RE. Array analyses of human whole blood changes in protein fractions. IVD Technology49–54 (2005).
   Google Scholar
• Tammen H, Schulte I, Hess R et al. Peptidomic analysis of human blood specimens: comparison between plasma specimens and serum by differential peptide display. Proteomics5(13), 3414–3422 (2005).
   PubMed Web of Science ®Google Scholar
• Evans MJ, Livesey JH, Ellis MJ, Yandle TG. Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones. Clin. Biochem.34(2), 107–112 (2001).
   PubMed Web of Science ®Google Scholar
• Guder WG, Narayanan S, Wisser H, Zawta B. Samples: From the Patient to the Laboratory. The Impact of Preanalytical Variables on the Quality of Laboratory Results 3rd Edition. Wiley-VCH, Germany (2003).
   Google Scholar
• Tammen H, Schulte I, Hess R, Menzel C, Kellmann M, Schulz-Knappe P. Prerequisites for peptidomic analysis of blood samples: I. Evaluation of blood specimen qualities and determination of technical performance characteristics. Comb. Chem. High Throughput Screen.8(8), 725–733 (2005).
   PubMed Web of Science ®Google Scholar
• Villanueva J, Shaffer DR, Philip J et al. Differential exoprotease activities confer tumor-specific serum peptidome patterns. J. Clin. Invest.116(1), 271–284 (2006).
   PubMed Web of Science ®Google Scholar
• Friedl P, Wolf K. Proteolytic and non-proteolytic migration of tumour cells and leucocytes. Biochem. Soc. Symp.70, 277–285 (2003).
   PubMedGoogle Scholar
• Goldberg DM. Proteases in the evaluation of pancreatic function and pancreatic disease. Clin. Chim. Acta291(2), 201–221 (2000).
   PubMed Web of Science ®Google Scholar
• Iwaki-Egawa S, Watanabe Y, Kikuya Y, Fujimoto Y. Dipeptidyl peptidase IV from human serum: purification, characterization, and N-terminal amino acid sequence. J. Biochem. (Tokyo)124(2), 428–433 (1998).
   PubMed Web of Science ®Google Scholar
• Joshi VD, Kalvakolanu DV, Cross AS. Simultaneous activation of apoptosis and inflammation in pathogenesis of septic shock: a hypothesis. FEBS Lett.555(2), 180–184 (2003).
   PubMed Web of Science ®Google Scholar
• Liotta LA, Petricoin EF. Serum peptidome for cancer detection: spinning biologic trash into diagnostic gold. J. Clin. Invest.116(1), 26–30 (2006).
   PubMed Web of Science ®Google Scholar
• Burtis CA, Ashwood ER, Tietz. Fundamentals of Clinical Chemistry. WB Saunders Company. (2001).
   Google Scholar
• Landi M, Caporaso N. Sample collection, processing, and storage. IARC Sci. Publ.142, 223–236 (1997).
   Google Scholar
• Holland NT, Smith MT, Eskenazi B, Bastaki M. Biological sample collection and processing for molecular epidemiological studies. Mutat. Res.543(3), 217–234 (2003).
   PubMed Web of Science ®Google Scholar
• House RV. Cytokine measurement techniques for assessing hypersensitivity. Toxicology158(1–2), 51–58 (2001).
   PubMed Web of Science ®Google Scholar
• Polack BMP, Barro C, Pernod G. Proceedings of the First Symposium on the Impact of the Pre-analytical Phase on the Quality of Laboratory Results in Haemostasis. Becton Dickinson, Montpellier (France) (1996).
   Google Scholar
• Adcock DM, Kressin DC, Marlar RA. Effect of 3.2% vs 3.8% sodium citrate concentration on routine coagulation testing. Am. J. Clin. Pathol.107(1), 105–110 (1997).
   PubMed Web of Science ®Google Scholar
• Engstad CS, Gutteberg TJ, Osterud B. Modulation of blood cell activation by four commonly used anticoagulants. Thromb. Haemost.77(4), 690–696 (1997).
   PubMed Web of Science ®Google Scholar
• Menssen HD, Melber K, Brandt N, Thiel E. The use of hirudin as universal anticoagulant in haematology, clinical chemistry and blood grouping. Clin. Chem. Lab. Med.39(12), 1267–1277 (2001).
   PubMed Web of Science ®Google Scholar
• Goosen W, Van Duppen V, Verwilghen RL. K2- or K3-EDTA: the anticoagulant of choice in routine hematology? Clin. Lab. Haematol.13, 291–295 (1991).
   PubMedGoogle Scholar
• Kerkay J, Coburn CM, McEvoy D. Effect of sodium ascorbate concentration on the stability of samples for determination of serum folate levels. Am. J. Clin. Pathol.68(4), 481–484 (1977).
   PubMedGoogle Scholar
• Comstock GW, Norkus EP, Hoffman SC, Xu MW, Helzlsouer KJ. Stability of ascorbic acid, carotenoids, retinol, and tocopherols in plasma stored at -70 degrees C for 4 years. Cancer Epidemiol. Biomarkers Prev.4(5), 505–507 (1995).
   PubMed Web of Science ®Google Scholar
• Lowik MR, Schrijver J, Wedel M. Vitamin C analysis in whole blood, plasma and cells using reduced glutathione as preservative (stabilizer): losses and redistribution. Int. J. Vitamins Nutr. Res.61(1), 43–45 (1991).
   PubMedGoogle Scholar
• Hulmes J. An investigation of plasma collection, stabilization and storage procedures for proteomic analysis of clinical samples. Clin. Proteomics1(1), 17–32 (2004).
   Google Scholar
• Bastaki M, Braiterman LT, Johns DC, Chen YH, Hubbard AL. Absence of direct delivery for single transmembrane apical proteins or their ‘secretory’ forms in polarized hepatic cells. Mol. Biol. Cell13(1), 225–237 (2002).
   PubMedGoogle Scholar
• Okumura N, Nomura M, Tada T et al. Effects of sample storage on serum C3 assay by immunonephelometry. Clin. Lab. Sci.3, 54–57 (1990).
   Google Scholar
• Ricos C, Alvarez V, Cava F et al. Current databases on biological variation: pros, cons and progress. Scand. J. Clin. Lab. Invest.59(7), 491–500 (1999).
   PubMed Web of Science ®Google Scholar
• Richtlinie der Bundesärztekammer zur Qualitätssicherung quantitativer laboratoriumsmedizinischer Untersuchungen98, B2356–B2367 (2001).
   Google Scholar
• Sonntag ORM, Haeckel R. Interferences. In: Evaluation Methods in Laboratory Medicine. Haeckel R (Ed.). AACC Press, 101–116 (1993).
   Google Scholar
• Tryding NTC, Sonntag O. Drug Effects in Clinical Chemistry, 7th Edition. AACC Press (1996).
   Google Scholar
• Young D. Effects of Drugs on Clinical Laboratory Tests, 4th Edition. AACC Press (1995).
   Google Scholar
• National Committe for Clinical and Laboratory Standards. Intereference testing in clinical chemistry; Proposed Guideline. NCCLS publication EP7–P (1986).
   Google Scholar
• Fuentes-Arderiu X, Fraser CG. Analytical goals for interference. Ann. Clin. Biochem.28(Pt 4), 393–395 (1991).
   PubMedGoogle Scholar
• Walser M. Grundlagen der Präanalytik: Praxisbezogene Tipps und Hinweise. Becton Dickinson GmbH, Heidelberg, Germany (2004).
   Google Scholar
• BD_Diagnostics. LabNotes15(1) (2005).
   Google Scholar
• Kleines Venenbrevier. Becton Dickinson GmbH, Heidelberg, Germany (2004).
   Google Scholar
• Refsum H, Smith AD, Ueland PM et al. Facts and recommendations about total homocysteine determinations: an expert opinion. Clin. Chem.50(1), 3–32 (2004).
   PubMed Web of Science ®Google Scholar
• Stanger O, Herrmann W, Pietrzik K et al. DACH-LIGA homocystein (German, Austrian and Swiss Homocysteine Society): consensus paper on the rational clinical use of homocysteine, folic acid and B-vitamins in cardiovascular and thrombotic diseases: guidelines and recommendations. Clin. Chem. Lab. Med.41(11), 1392–1403 (2003).
   PubMed Web of Science ®Google Scholar
• Aziz N, Nishanian P, Mitsuyasu R, Detels R, Fahey JL. Variables that affect assays for plasma cytokines and soluble activation markers. Clin. Diagn. Lab. Immunol.6(1), 89–95 (1999).
   PubMedGoogle Scholar
• Biobank TU. Sample Handling and Storage Subgroup Protocol and Recommendations, UK Biobank (2004).
   Google Scholar
• Pahl A, Brune K. Gene expression changes in blood after phlebotomy: implications for gene expression profiling. Blood100(3), 1094–1095 (2002).
   PubMed Web of Science ®Google Scholar
• West-Nielsen M, Hogdall EV, Marchiori E, Hogdall CK, Schou C, Heegaard NH. Sample handling for mass spectrometric proteomic investigations of human sera. Anal. Chem.77(16), 5114–5123 (2005).
   PubMed Web of Science ®Google Scholar
• de Lemos JA, Zirlik A, Schonbeck U et al. Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart Study. Arterioscler. Thromb. Vasc. Biol.25(10), 2192–2196 (2005).
   PubMed Web of Science ®Google Scholar
• Lathrop JT, Anderson NL, Anderson NG, Hammond DJ. Therapeutic potential of the plasma proteome. Curr. Opin. Mol. Ther.5(3), 250–257 (2003).
   PubMedGoogle Scholar
• Lammers M. Dilution of citrated plasma. Eur. J. Clin. Chem. Clin. Biochem.34(4), 369 (1996).
   PubMedGoogle Scholar
• Heins M, Heil W, Withold W. Storage of serum or whole blood samples? Effect of time and temperature on 22 serum analytes. Eur. J. Clin. Chem. Clin. Biochem.33, 231–238 (1995).
   Google Scholar
• Kreutzer HJH, Paanakker MPWM. Stability of routine chemistry parameters in lithium heparin gel tubes. Proc. 11th Eur. Cong. Clin. Chem., Tampere, Finland (1995) (Abstract 357).
   Google Scholar
• Lammers M, Rausch S. Suitability of plasma specimen for immunonephelometric protein assays. Clin. Chem. Lab. Med.40, 114 (2002).
   Google Scholar
• Thomas L. Clinical Laboratory Diagnosis. TH-Books, Frankfurt, Germany (1998).
   Google Scholar
• Tietz NW. Clinical Guide to Laboratory Tests (3rd Edition). Saunders, PA, USA (1995).
   Google Scholar
• Töpfer G, Hornig F, Sauer K, Zawta B. Untersuchungen zur Stabilität von 11 Serumproteinen bei Bestimmung mit Immunturbidimetrie. J. Lab. Med.24, 118–125 (2000).
   Google Scholar
• Narayanan S. The preanalytical phase. An important component of laboratory medicine. Am. J. Clin. Pathol.113, 429–452 (2000).
   Google Scholar
• Numata Y, Doki K, Furukawa Akikuoka S, et al. Immunoradiometry assay for the N-terminal fragment of proatrial natriuretic peptide in human plasma. Clin. Chem.44, 1008–1013 (1998).
   Google Scholar
• Fsuji T, Masuda H, Imagawa K et al. Stability of human natriuretic peptide in blood samples. Clin. Chim. Acta225, 171–177 (1994).
   Google Scholar
• Merve D, Henley R, Lane G et al. Effect of different sample types and stability after blood collection of N-Terminal proB type natriuretic peptide as measured with the Roche Elecsys system. Clin. Chem.50, 779–780 (2004).
   Google Scholar
• Bidart JM, Thuillier F, Augereau C et al. Kinetics of serum tumor marker concentrations and usefulness in clinical monitoring. Clin. Chem.45(10), 1695–1707 (1999).
   Google Scholar
• Schmitt UM, Stieber P, Pahl H, Reinmiedl J, Fateh-Moghadam A. Stabilität tumorassoziierter Antigene in Vollblut und Serum. J. Lab. Med.24, 475 (2000).
   Google Scholar
• Stieber P. Maligens Wachstum in Guber WG, Nolte J. Das Laborbuch für Klinik und Praxis. Elsevier Urban und Fischer, Munich, Germany (2005).
   Google Scholar
• Sölétormos G, Schioler V, Nielsen D, Skovsgaard T, Dombernowsky P. Interpretation of results for tumor markers on the basis of analytical imprecision and biological variation. Clin. Chem. (1993).
   Google Scholar
• Okabe R, Nakatsuka K, Inaba M et al. Clinical evaluation of the Elecsys β-CrossLaps serum assay, a new assay for degradation products of type I collagen C-telopeptides. Clin. Chem.47, 1410–1414 (2001).
   Google Scholar
• Kendall RG, Chapman C, Hartley AE et al. Storage and preparation of samples for erythropoietin radioimmunoassay. Clin. Lab. Haematol.13, 189–196 (1991).
   Google Scholar
• Narayanan S. Protection of peptidic subtrates by protease inhibitors. Biochem. Clin.11, 954–956 (1987).
   Google Scholar
• Töpfer G, Funke U, Schulze M et al. Determination of coagulation parameteres in citrated venous blood, catheter blood, and capillary blood: preanalytical problems.J. Lab. Med.24, 514–520 (2000).
   Google Scholar
• Wallace AM. Measurement of leptin and leptin binding in the human circulation. Ann. Clin. Biochem.37, 244–252 (2000).
   Google Scholar
• Lippi G, Giampaolo L, Guidi G et al. Effects of anticoagulants on lipoprotein(a) measurements with four commercial assays.Eur. J. Clin. Chem. Clin. Biochem.34, 251–255 (1996).
   Google Scholar
• Pai JK, Curhan GC, Cannuscio CC et al. Stability of novel plasma markers associated with cardiovascular disease: processing within 36 hours of specimen collection. Clin. Chem.48, 1781–1784 (2002).
   Google Scholar
• Pantheghini M, Pagoni F. Pre-analytical, analytical and biological sources of variation of lipoprotein(a). Eur. J. Lab. Med.31, 23–28 (1993).
   Google Scholar
• Sharma A, Anderson K, Baker JW et al. Flocculation of serum lipoproteins with cyclodextrins: application to assay of hyperlipidemic serum. Clin. Chem.36, 529–532 (1990).
   Google Scholar
• Simó JM, Camps J, Vilella E et al. Instability of lipoprotein(a) in plasma stored at -70 degrees C: effects of concentration, apolipoprotein(a) genotype, and donor cardiovascular disease.Clin. Chem.47(9), 1673–1678 (2001).
   Google Scholar
• Conrad K. Autoimmunerkrankungen. In: Das Laborbuch für Klinik und Praxis. Guder WG, Nolte J (Eds). Elsevier Urban und Fischer, Munich, Germany (2005).
   Google Scholar
• Chekhonin VP, Zhirkov YA, Belyaeva IA et al. Serum time course of two brain-specific proteins, α(1) brain globulin and neuron-specific enolase, in tick-born encephalitis and Lyme disease. Clin. Chem. Acta320(1–2), 117–125 (2002).
   Google Scholar
• Gross J, Ungethüm U, Moller R et al. Preanalytical factors influencing the measurement of NSE levels in blood. J. Lab. Med.18, 286 (1995).
   Google Scholar
• Heil W, Grunewald R, Amend M et al. Influence of time and temperature on coagulation analytes in stored plasma.Clin. Chem. Lab. Med.36(7), 459–462 (1998).
   Google Scholar
• Luddington R, Peters J, Baker P et al. The effect of delayed analysis or freeze-thawing on the measurement of natural anticoagulants, resistance to activated protein C and markers of activation of the haemostatic system.Thromb. Res.87(6), 577–581 (1997).
   Google Scholar
• De Jongh R, Vranken J, Vundelinckx G et al. The effects of anticoagulation and processing on assays of IL-6, sIL-6R, sIL-2R and soluble transferrin receptor.Cytokine9(9), 696–701 (1997).
   Google Scholar
• Lammers M, Rausch S. Suitability of plasma specimen for immunonephelometric protein assays. Clin. Chem. Lab. Med.40, 114 (2002).
   Google Scholar
• Narayanan S. Quality control in tumor marker analysis: pre-analytical issues. J. Clin. Ligand Assay21, 11–17 (1998).
   Google Scholar
• Schmitt UM, Stieber P, Pahl H, Teinmiedl J, Fateh-Moghadam A. Stabilität tumorassoziierter Antigene in Vollblut und Serum. J. Lab. Med.24, 475 (2000).
   Google Scholar